Multiple Sclerosis
Conference Coverage
Does the EDSS Capture Cognitive Difficulties in Patients With MS?
LONDON—The Expanded Disability Status Scale (EDSS) is largely insensitive to cognitive ability in patients with multiple...
Conference Coverage
Can Neurologists Predict Long-Term Disability Trajectories in Primary Progressive MS?
LONDON—A dynamic model based on long-term observations and a statistical modeling approach can help neurologists predict the...
Conference Coverage
Telerehabilitation May Be As Effective As In-Person Rehabilitation in MS
LONDON—In patients with multiple sclerosis (MS), telerehabilitation is a convenient and practical method of performing physical...
Conference Coverage
Retinal Measurements Predict 10-Year Disability in MS
LONDON—As has been previously shown with brain atrophy and lesion volume, retinal measures can have predictive value for medium-...
Conference Coverage
Durable Efficacy of Cladribine Tablets After Conversion to Clinically Definite MS
LONDON—Significant treatment effect versus placebo of cladribine tablets given to patients with clinically isolated syndrome...
Conference Coverage
Demyelinating Diseases Are Associated With Psychiatric Disorders in Children
LONDON—Strong evidence suggests an association between pediatric CNS demyelinating diseases and psychiatric disorders, according...
Conference Coverage
Evaluation of Cortical Lesions Could Improve Diagnosis of MS
LONDON—Evaluation of cortical lesions improves specificity of the diagnostic criteria for multiple sclerosis (MS), according to...
Conference Coverage
Th17 Cells Are Activated in the Gut of Patients With MS
LONDON—Data suggest a selective activation of Th17 cells in the intestinal mucosa of patients with multiple sclerosis (MS),...
Literature Review
Multiple Sclerosis Is Associated With Changes in the Gut Microbiome
Researchers have found a correlation between multiple sclerosis (MS) and changes in the human gut microbiome, according to data published June 28...
Literature Review
Abatacept Fails to Provide Benefits in Relapsing MS
Abatacept does not reduce the number of new gadolinium-enhancing lesions on MRI in patients with relapsing-remitting multiple sclerosis (MS),...